欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2008, Vol. 13 ›› Issue (10): 1104-1108.

• 基础研究 • 上一篇    下一篇

曲格列酮对白血病 NB4 细胞的增殖抑制作用及其作用机制

徐妍1, 胡婷1, 王春芝1, 刘培庆2, 林东军1, 肖若芝1, 刘加军1   

  1. 1中山大学附属三院血液内科, 广州 510630, 广东;
    2中山大学药理与毒理教研室, 广州 510630, 广东
  • 收稿日期:2008-08-23 修回日期:2008-10-09 出版日期:2008-10-26 发布日期:2020-10-19
  • 通讯作者: 刘加军, 男, 博士后, 副教授, 硕士研究生导师, 研究方向:血液肿瘤的分子靶向治疗。Tel:020-85252227  E-mail:jiajunliu2002@yahoo .com.cn
  • 作者简介:徐妍, 女, 在读硕士研究生, 研究方向:血液肿瘤基础与临床研究。Tel:020-85252227   E-mail:xuyan5584@yahoo.com.cn
  • 基金资助:
    国家自然科学基金项目(30570782); 教育部新世纪优秀人才支持计划资助项目(NCET-06-0721); 广东省自然科学基金课题(8151008901000128)

Anti-proliferation effect of troglitazone on NB4 cells and its mecha-nisms of action

XU Yan1, HU Ting1, WANG Chun-zhi1, LIU Pei-qing2, LIN Dong-jun1, XIAO Ruo-zhi1, LIU Jia-jun1   

  1. 1Department of Hematology, the Third Hospital of Sun Yat-SenUniversity, Guangzhou510630, Guangdong, China;
    2Department of Pharmacology and Toxicology of Sun Yat-Sen University, Guangzhou 510630,Guangdong,China
  • Received:2008-08-23 Revised:2008-10-09 Online:2008-10-26 Published:2020-10-19

摘要: 目的: 探讨过氧化物酶体增殖物激活受体γ(PPARγ) 激动剂曲格列酮(troglitazone, TGZ) 对白血病NB4 细胞的增殖抑制作用及其作用机制。方法: 以不同浓度的 TGZ(0~ 80 μmol/L)作用于体外培养的NB4细胞0、24、48、72 h,应用MTT 法检测细胞生长抑制率, Hoechst33258 染色法检测细胞凋亡,琼脂糖凝胶电泳观察细胞凋亡时的 DNA梯状条 带。用免 疫印迹法(Western Blot) 检测Caspase-3及其裂解底物多聚(ADP-核糖) 聚合酶PARP[(poly(ADP-ribose) polymerase) ] 表达水平的变化, 并对凋亡调节蛋白 Bax 及 Bcl-2 的表达水平进行检测 。结果: 20 μmol/L 以上的 TGZ 可显著抑制细胞的生长, 在Hoechst 染色后可见典型的细胞凋亡现象, 并呈现出明显的量-效与时-效关系, 药物作用 72 h 后在琼脂糖凝胶电泳上可见明显的DNA 梯 状条 带。Western Blot 检测结 果表 明,Caspase-3 被活化出现 20000 的亚单位, 同时 PARP被裂解出现 89000的亚单位片段。药物作用 48 h后凋亡抑制蛋白 Bcl-2 的表达水平明显降低, 而促凋亡蛋白 Bax 的表达水平显著升高。结论: TGZ能显著抑制 NB4 细胞的生长并诱导细胞发生凋亡, 通过激活 Caspase-3 以及降低 Bcl-2、升高 Bax的表达水平是 TGZ 诱导细胞发生凋亡的重要作用机制 ;这些结果表明 TGZ 是一种潜在的抗白血病药物。

关键词: 曲格列酮, 白血病, 细胞凋亡

Abstract: AIM: To investigate the anti-prolifera-tion effect of peroxisome proliferator-activated receptor γ(PPARγ) agonist troglitazone (TGZ ) on leukemic NB4 cells and its mechanisms of action.METHODS: NB4 cells in culture medium in vitro were given differ-ent concentrations of TGZ (0-80 μmol/L) for 24, 48 and 72 h .The inhibitory rate of the cells were mea-sured by MTT assay .Cell apoptosis were observed by flow cytometry (FCM) and DNA fragmentation was as-sayed by agarose gel electrophoresis.Bcl-2 and Bax as well as Caspase-3 and poly(ADP-ribose) polymerase (PARP) expressionwere detected by Western blotting . RESULTS: TGZ (over 20 μmol/L) could inhibit the growth of NB4 cells and cause apoptosis remarkably . Furthermore, the suppression was both in time-and dose-dependent manner.DNA ladder was observed af-ter the cells treated by TGZ for 72 h, and marked mor-phological changesof cell apoptosis such as condensati-on of chromatin was clearly observed by Hoechst stain-ing .Western blotting showed cleavage of the Caspase-3 zymogen protein (32000) , with the appearance of its 20000 subunit, and a cleaved 89000 fragment of 116000 PARP was also found.Furthermore, western blotting also showed that anti-apoptotic protein Bcl-2 was decreased remarkably while pro-apoptotic protein Bax increased significantly after the cells were treated by TGZ for 48 h.CONCLUSION: TGZ can inhibit cell growth and induce apoptosis of NB4 cells via acti-vation of Caspase-3 as well as downregulation of Bcl-2 and upregulation of bax expression in NB4 cells.The results indicate that TGZ might be an important poten-tial anti-leukaemia reagent .

Key words: troglitazone, leukemia, apoptosis

中图分类号: